Institutional Ownership
Arrowhead Pharmaceuticals In
CUSIP 04280A100COMARWRQ1 2026
Institutional Holders
423
13F filers
Shares Held
106.38M
Aggregate institutional
Institutional Value
$6.54B
Q1 2026
Net New Holders
+34
91 new · 57 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions91
Increased168
Decreased113
Sold out57
Institutional Holders
423 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 18.16M | $1.14B | −3.16M | Reduced |
| 2 | Avoro Capital Advisors LLC | 10.70M | $670.89M | +75.0K | Added |
| 3 | Fmr LLC | 7.27M | $455.62M | +746.2K | Added |
| 4 | State Street Corp | 6.50M | $407.31M | +92.3K | Added |
| 5 | Geode Capital Management, LLC | 4.28M | $274.50M | +1.01M | Added |
| 6 | Fred Alger Management, LLC | 3.34M | $209.57M | +1.51M | Added |
| 7 | Invesco Ltd. | 3.28M | $205.70M | +2.73M | Added |
| 8 | Vestal Point Capital, LP | 2.27M | $142.64M | +1.38M | Added |
| 9 | Baker Bros. Advisors LP | 1.99M | $124.95M | −182.9K | Reduced |
| 10 | Goldman Sachs Group Inc | 1.74M | $109.09M | +62.4K | Added |
413 more institutional holders on Premium
See every fund holding Arrowhead Pharmaceuticals In, with full quarter-over-quarter share changes.
Unlock all holders